UTAH MEDICAL PRODUCTS INC
For the period ended Jun 30, 2026. Filed Aug 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 12, 2026
UTMD$72.23+1.7%Stored close · as of Nov 6, 2026
Contents
Item 1. Financial Statements
| Consolidated Condensed Balance Sheets as of June 30, 2026 and December 31, 2025 | 1 | |
| Consolidated Condensed Statements of Income for the three and six months ended June 30, 2026 and June 30, 2025 | 2 | |
| Consolidated Condensed Statements of Cash Flows for the six months ended June 30, 2026 and June 30, 2025 | 3 | |
| Consolidated Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2026 and June 30, 2025 | 4 | |
| Notes to Consolidated Condensed Financial Statements | 5 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 8 |
|---|---|---|
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 17 |
| Item 4. | Controls and Procedures | 17 |
| PART II – OTHER INFORMATION | ||
| Item 1. | Legal Proceedings | 18 |
| Item 1A. | Risk Factors | 18 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 18 |
| Item 6. | Exhibits | 19 |
| SIGNATURES | 20 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.